GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for anaerobic ribonucleoside- triphosphate reductase-activating protein (Q9L645)

Analyse AlphaFold monomer V2.0 prediction for anaerobic ribonucleoside- triphosphate… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
Q9L645
Type
protein
Length
154 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x7782F4817b37743d738e9aF842bf74bd50f2015E
Molecule
Anaerobic ribonucleoside-triphosphate reductase-activating protein
UniProt
Q9L645
Pockets
1 · best druggability 0.67

Structure

1 distinct chain · 27% helix, 25% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAnaerobic ribonucleoside-triphosphate reductase-activating proteinprotein15427% helix, 25% strandQ9L645

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12520.670.8433empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.